sensiparhcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Sitemap: | ||
Meta Tags
| Title | www.sensiparhcp.com |
| Description | Read More Indication and Limitations of Use Sensipar® (cinacalcet) is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 52.41.203.130 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
sensiparhcp.com Valuation
|
US$3,566,954
Last updated: 2023-05-13 18:32:32
sensiparhcp.com has Semrush global rank of 2,967,323. sensiparhcp.com has an estimated worth of US$ 3,566,954, based on its estimated Ads revenue. sensiparhcp.com receives approximately 411,572 unique visitors each day. Its web server is located in United States, with IP address 52.41.203.130. According to SiteAdvisor, sensiparhcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$3,566,954 |
| Daily Ads Revenue | US$3,293 |
| Monthly Ads Revenue | US$98,778 |
| Yearly Ads Revenue | US$1,185,327 |
| Daily Unique Visitors | 27,439 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| sensiparhcp.com. | A | 299 | IP: 52.41.203.130 |
| sensiparhcp.com. | A | 299 | IP: 34.212.77.168 |
| sensiparhcp.com. | NS | 86400 | NS Record: ns-275.awsdns-34.com. |
| sensiparhcp.com. | NS | 86400 | NS Record: ns-885.awsdns-46.net. |
| sensiparhcp.com. | NS | 86400 | NS Record: ns-1046.awsdns-02.org. |
| sensiparhcp.com. | NS | 86400 | NS Record: ns-1651.awsdns-14.co.uk. |
| sensiparhcp.com. | MX | 300 | MX Record: 3 amgen-com.mail.protection.outlook.com. |
HtmlToTextCheckTime:2023-05-13 18:32:32
| Read More Indication and Limitations of Use Sensipar® (cinacalcet) is indicated for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on dialysis. Sensipar® is not indicated for use in patients with CKD who are not on dialysis because of an increased risk of hypocalcemia. FOR ADULT PATIENTS ON DIALYSIS WITH SECONDARY HPT FULL PRESCRIBING INFORMATION INDICATION IMPORTANT SAFETY INFORMATION OTHER INDICATIONS FOR PATIENTS SECONDARY HPT THERAPIES CLINICAL DATA DOSING PERSISTENCE COVERAGE Smart Start & Resources Full Prescribing Information Indications Other Indications Site Map Amgen Med Info For Patients Joe HYPOTHETICAL PATIENT WITH SECONDARY HPT 6 month ago 3 month ago Now iPTH (pg/mL) 650 550 530 Calcium (mg/dL) 9.4 9.5 9.6 Phosphorus (mg/dL) 5.4 5.7 5.8 IV doxercalciferol per treatment 2.0 µ g 3.0 µ g HPT = hyperparathyroidism; iPTH = intact parathryoid hormone; IV = intravenous; sHPT = secondary hyperparathyroidism; PTH = |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Tue, 21 Dec 2021 22:10:37 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 147 Connection: keep-alive Set-Cookie: AWSALB=OOKUZuA1pmrcorYyGhVuCfDETgjySBcp+GYtpxJeU3DIiqzI7ydOnHRunMS0z7ofgRxB+uAlp3t7rQrxe+VgNraXRF/DQGc8dL6rYTelWMfBvimkVJr8qZGfxx5H; Expires=Tue, 28 Dec 2021 22:10:37 GMT; Path=/ Set-Cookie: AWSALBCORS=OOKUZuA1pmrcorYyGhVuCfDETgjySBcp+GYtpxJeU3DIiqzI7ydOnHRunMS0z7ofgRxB+uAlp3t7rQrxe+VgNraXRF/DQGc8dL6rYTelWMfBvimkVJr8qZGfxx5H; Expires=Tue, 28 Dec 2021 22:10:37 GMT; Path=/; SameSite=None Location: https://sensiparhcp.com/ Strict-Transport-Security: max-age=31536000 Content-Security-Policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com https://dusandbox.skipta.com https://doctorunite.com https://generationNP.com https://cardiologistconnect.com https://paunite.com https://cardiologistconnectsandbox.skipta.com https://next.brella.io/ X-Frame-Options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com X-Xss-Protection: 1; mode=block HTTP/2 301 date: Tue, 21 Dec 2021 22:10:38 GMT content-type: text/html; charset=UTF-8 content-length: 151 location: https://www.sensiparhcp.com/ set-cookie: AWSALB=+oAPg7wHHpUsxLJVZ0aCnmEiMQOJLm5UYBQarFxC9OWhCd9UYRVDhS0GQ4+meS8Lh2xyhB89a/FjPlMI3ZHZUjUUXf9BI155VfzO3yk8kOPppB5GBtgRhA9+9MKZ; Expires=Tue, 28 Dec 2021 22:10:38 GMT; Path=/ set-cookie: AWSALBCORS=+oAPg7wHHpUsxLJVZ0aCnmEiMQOJLm5UYBQarFxC9OWhCd9UYRVDhS0GQ4+meS8Lh2xyhB89a/FjPlMI3ZHZUjUUXf9BI155VfzO3yk8kOPppB5GBtgRhA9+9MKZ; Expires=Tue, 28 Dec 2021 22:10:38 GMT; Path=/; SameSite=None; Secure strict-transport-security: max-age=31536000 content-security-policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com https://dusandbox.skipta.com https://doctorunite.com https://generationNP.com https://cardiologistconnect.com https://paunite.com https://cardiologistconnectsandbox.skipta.com https://next.brella.io/ x-frame-options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-xss-protection: 1; mode=block HTTP/2 200 date: Tue, 21 Dec 2021 22:10:38 GMT content-type: text/html; charset=utf-8 content-length: 34788 set-cookie: AWSALB=hryKsGRaplexOYsyVt+STl8aWRbobMbFvqqHnHnmS2K4OoBGwpkRHgo0dh6SMck4ZC81p/OzMDYs9YpZqnK+hxTSiQCDk+VeJ/6ilQyXaHhAJ/E2gyjuAJIuPz9V; Expires=Tue, 28 Dec 2021 22:10:38 GMT; Path=/ set-cookie: AWSALBCORS=hryKsGRaplexOYsyVt+STl8aWRbobMbFvqqHnHnmS2K4OoBGwpkRHgo0dh6SMck4ZC81p/OzMDYs9YpZqnK+hxTSiQCDk+VeJ/6ilQyXaHhAJ/E2gyjuAJIuPz9V; Expires=Tue, 28 Dec 2021 22:10:38 GMT; Path=/; SameSite=None; Secure cache-control: private strict-transport-security: max-age=31536000 content-security-policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com https://dusandbox.skipta.com https://doctorunite.com https://generationNP.com https://cardiologistconnect.com https://paunite.com https://cardiologistconnectsandbox.skipta.com https://next.brella.io/ x-frame-options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-xss-protection: 1; mode=block |
sensiparhcp.com Whois Information
Domain Name: SENSIPARHCP.COM Registry Domain ID: 1555601290_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-04-11T09:09:32Z Creation Date: 2009-05-13T23:06:52Z Registry Expiry Date: 2023-05-13T23:06:52Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1046.AWSDNS-02.ORG Name Server: NS-1651.AWSDNS-14.CO.UK Name Server: NS-275.AWSDNS-34.COM Name Server: NS-885.AWSDNS-46.NET DNSSEC: unsigned >>> Last update of whois database: 2021-12-25T07:27:19Z <<< |